Mid banner advertisement: BDO
ARM Innovation Hub
Advertisement: Wild Knight Vodka
Advertisement – Charles Stanley mid banner
Advertisement: EBCam mid banner
Advertisement: Mogrify mid banner
Advertisement: Cambridge Network mid banner
Advertisement: Simpsons Creative
RealVNC mid banner careers
Advertisement: TTP
Advertisement: S-Tech mid banner 3
Barr Ellison Solicitors – commercial property
Advertisement: Howard Group mid banner
Advertisement: Hewitsons mid banner
Advertisement: Kao Data Centre mid banner
Advertisement: RSM
Advertisement: EY Mid banner
2 April, 2020 - 16:15 By Kate Sweeney

Eagle in rudest of health after tie-up with hygiene specialist

UK-based global health and hygiene company RB is collaborating with Eagle Genomics in Cambridge in a research project designed to simplify development of new and improved consumer products. A successful pilot programme has already been completed.

RB – short for Reckitt Benckiser – makes brands such as Lysol, Air Wick, Mucinex, Enfamil and many more. Eagle Genomics, based at the Wellcome Genome Campus in Cambridge, is in demand for its  life sciences knowledge discovery platform.

Chris Jones, vice-president of R & D Hygiene at RB, said: “As a company driven by innovation, RB collaborates with partners who bring powerful new capabilities to the table so we can deliver disruptive ideas to the market, which is exactly why we’re working with Eagle Genomics.

“Already with the use of Eagle Genomics’ application of data science and machine learning modelling, RB has been able to accelerate scientific discovery of novel antimicrobial compounds beyond traditional capabilities, which is especially important given today’s health landscape.”

The collaboration will further digitise the company’s research and development technical expertise, allowing for faster innovation and product development to meet increasing consumer needs in important hygiene and health categories.

Anthony Finbow, CEO at Eagle Genomics., said: “With this partnership, Eagle Genomics and RB will create a collaborative, cloud-based data management and analytics platform on which RB will be able to organise and compound their R & D technical expertise.

“We’re proud that our platform will allow RB to prioritise discovery and invention of viable new products for consumers all over the world, particularly in exciting new research areas such as the microbiome.”

In its initial case study, RB utilised Eagle Genomics’ platform algorithms to process over 50 databases and 140,000 publications containing nearly 100,000,000 compounds in record time. 

Each database was analysed alongside RB’s in-house data and expertise, according to its relevance, accessibility, stability, and the quality of data. The effort resulted in accelerated learnings which provided positive proof that expanded use of the platform will enhance RB’s overall R & D capabilities.

Through its two business units, Health and Hygiene Home, RB has operations in over 60 countries and its products reach millions of people globally every day. Its household brands include names such as Enfamil, Nutramigen, Mucinex, Delsym, Durex, K-Y, Clearasil, Airborne, Digestive Advantage, MegaRed, Move Free, Neuriva, Lysol, Finish, Woolite and Air Wick.

• To read the latest edition of Business Weekly visit https://bit.ly/2xMd8Di

Newsletter Subscription

Stay informed of the latest news and features